Clinical Trials Browser

Has results × Arthritis, Rheumatoid × Rituximab × Clear all

NCT00503425 2017-08-15

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Phase 3 Completed

215 enrolled 9 charts

Arthritis, Rheumatoid

NCT00468546 2016-10-25

A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Phase 3 Completed

520 enrolled 17 charts

Arthritis, Rheumatoid

NCT01613027 2016-10-24

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

135 enrolled 21 charts

Arthritis, Rheumatoid

NCT01641952 2016-08-17

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

505 enrolled 15 charts

Arthritis, Rheumatoid